Published in Cancer Weekly, May 23rd, 2000
"The prognosis for survival of patients infected with the human immunodeficiency virus (HIV) who develop non-Hodgkin lymphoma (NHL) usually is considered poor," F. Thiessard and associates said in the journal Cancer.
Thus, Thiessard and colleagues at the University Victor Segalen in Bordeaux, France undertook a study which would identify the factors that most identify the risk of an early death in these patients. Using in-depth statistical analysis, the researchers reviewed 12 years worth of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.